Startups

Redwood Neuro
Irvine, California, United States
Redwood Neuro Inc. is an Irvine, California biotechnology company developing ultrasensitive blood-based biomarker assays for Alzheimer's disease and other disease-detection applications. Its NIH-supported SiMoLiSA research aims to create an accessible multiplex assay for Alzheimer's biomarkers and validate it using clinical samples. NIH's National Institute on Aging awarded the company USD506,061 in September2025 for a PhaseI SBIR project led by Murat Baday with co-investigator Ahmet Ali Yanik. These published research affiliations are recorded without assuming executive titles or full-time employment. The company's website describes diagnostic performance ambitions, but clinical approval, validated15-year prediction, commercial effectiveness and undisclosed private financing are not independently established by the sources reviewed. No public executive directory or named private investors were found.

